As long as pharmaceutical tariffs are being considered, their potential threat to the pharmaceutical industry and the people ...

President Trump spared pharmaceuticals from the opening salvo in his campaign to transform the economy through “reciprocal” ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

CLSA said that even if tariffs are imposed, Indian drug makers are likely to pass on the costs, given their dominant market ...

As per an analysis of the GTRI, the hardest-hit sector in agriculture would be fish, meat, and processed seafood, with $2.58 ...

Indian pharmaceutical exports to the U.S. were valued at approximately USD 8 billion, with the industry witnessing an 8 percent compound annual growth rate (CAGR) over FY15-24.

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

"Ceramic, glass, and stone products, with USD 1.71 billion in exports, will face an 8.27 per cent tariff, impacting demand.

GROUPE LSL PHARMA INC (TSXV: LSL) (TSXV: LSL.DB) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical ...

The recent imposition of a 27 per cent reciprocal tariff on Indian exports by the United States, while exempting the ...

Pharma: However, to fully leverage these opportunities, India has to enhance its ease of doing business, invest in logistics ...